comparemela.com

Latest Breaking News On - பயோடெக் சர்வதேச வரையறுக்கப்பட்டவை - Page 1 : comparemela.com

Bharat Biotech submits new request to Brazilian regulator on GMP issues for Covaxin

COVID-19: Bharat Biotech Submits New Request To Brazilian Regulator On Good Manufacturing Practices For Covaxin

Bharat Biotech has signed an agreement with Brazil for supply of 20 million doses of Covaxin. Hyderabad: Bharat Biotech which faced a red flag from Brazil s health regulator for supply of COVID-19 vaccine Covaxin to that country over the issues of Good Manufacturing Practices in its plant, has filed a new request to the Brazilian authorities for certification. According to the National Health Surveillance Agency of Brazil Anvisa, Bharat Biotech made the request on May 25 and a day before the Ministry of Health of the South American country filed a new application for authorisation to import 20 million doses of the Covaxin.

Startup news and updates: daily roundup (May 25, 2021)

WhatsApp on Monday said it would not limit the functionality for users not agreeing to its new privacy policy but will continue to remind users about the update, and maintain this approach till the forthcoming data protection law comes into effect. Days after the government directed the messaging platform to withdraw its new privacy policy, a WhatsApp spokesperson said the company had responded to the letter and has assured that the privacy of users remains the highest priority for the Facebook-owned entity. Bharat Biotech International Limited (BBIL) has conveyed to the government that it has submitted 90 percent of the documentation to the WHO for obtaining an emergency use listing for the Covaxin vaccine and the remaining details will be supplied next month, sources said on Monday.

Bharat Biotech awaits emergency use approval from WHO for COVID-19 vaccine

Bharat Biotech awaits emergency use approval from WHO for COVID-19 vaccine Firstpost 5 days ago © Provided by Firstpost Bharat Biotech awaits emergency use approval from WHO for COVID-19 vaccine Bharat Biotech International Limited (BBIL) has applied to the World Health Organisation (WHO) to get an emergency use listing (EUL) for its COVID-19 vaccine. It hopes to get the nod by the third or fourth quarter of this year. BBIL has submitted 90 percent of required documents to WHO to get approval, and the remaining documents will be submitted by June, the Hyderabad-based pharma company told the Central government during a discussion. The meeting was attended by the company s managing director V Krishna Mohan and his colleagues, along with senior officers of the Ministry of Health, Department of Biotechnology and Ministry of External Affairs and Foreign Secretary Harsh Vardhan Shringla. Speaking to 

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.